Zhejiang Xianju Pharmaceutical Co.,Ltd. (SHE:002332)
China
· Delayed Price · Currency is CNY 8.81
+0.04 (0.46%)
Apr 29, 2026, 3:04 PM CST
SHE:002332 Revenue
Zhejiang Xianju Pharmaceutical had revenue of 918.35M CNY in the quarter ending March 31, 2026, a decrease of -8.91%. This brings the company's revenue in the last twelve months to 3.67B, down -7.60% year-over-year. In the year 2025, Zhejiang Xianju Pharmaceutical had annual revenue of 3.76B, down -6.04%.
Revenue (ttm)
3.67B
Revenue Growth
-7.60%
P/S Ratio
2.38
Revenue / Employee
1.14M
Employees
3,205
Market Cap
8.71B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.76B | -241.72M | -6.04% |
| Dec 31, 2024 | 4.00B | -122.73M | -2.98% |
| Dec 31, 2023 | 4.12B | -256.41M | -5.85% |
| Jan 1, 2023 | 4.38B | 22.48M | 0.52% |
| Jan 1, 2022 | 4.36B | 338.47M | 8.42% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chongqing Taiji Industry(Group) Co.,Ltd | 10.50B |
| Frontier Biotechnologies | 392.19M |
| Changzhou Qianhong Biopharma CO.,LTD | 1.48B |
| Shandong Lukang Pharmaceutical | 5.71B |
| HARBIN GLORIA PHARMACEUTICALS Co., LTD | 2.14B |
| Shenzhen Neptunus Bioengineering | 27.28B |
| Sichuan Huiyu Pharmaceutical | 1.03B |
| Hunan Er-Kang Pharmaceutical | 1.06B |